Covered recipient · General Payments record
DAWN M BARROM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$795.88
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.92 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $205.00 | 8 |
| Lilly USA, LLC | $50.17 | 3 |
| Currax Pharmaceuticals LLC | $28.75 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.72 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089520967 | CMS |
| Currax Pharmaceuticals LLC | $14.03 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089520970 | CMS |
| Lilly USA, LLC | $13.70 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135566724 | CMS |
| Lilly USA, LLC | $14.51 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135566726 | CMS |
| Lilly USA, LLC | $21.96 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135604327 | CMS |
| Novo Nordisk Inc | $24.83 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100485981 | CMS |
| Novo Nordisk Inc | $12.51 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100536131 | CMS |
| Novo Nordisk Inc | $17.50 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100255326 | CMS |
| Novo Nordisk Inc | $116.68 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100386877 | CMS |
| Novo Nordisk Inc | $10.56 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473484 | CMS |
| Novo Nordisk Inc | $12.66 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100377267 | CMS |
| Novo Nordisk Inc | $5.13 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100601815 | CMS |
| Novo Nordisk Inc | $5.13 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100364727 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.